| Certification: | ISO, FDA, HACCP |
|---|---|
| Assay Method: | HPLC |
| Application Form: | Paste, Tablet, Capsule |
| Application: | Food, Health Care Products |
| State: | Powder |
| Extract Source: | Haematococcus Pluvialis |
| Samples: |
|---|
| Customization: |
|---|
Suppliers with verified business licenses
Audited Supplier
Product Name: Astaxanthin
Botanic Name: Haematococcus pluviali
Specification: 5%~50% Astaxathin by HPLC
Test Method:HPLC
Part of used: Thallus
Appearance: Dark red
| PRODUCT SPECIFICATIONS | ||
| Product Name: | Astaxanthin | |
| Botanic Name: | Haematococcus pluvialis | |
| Scientific name(Family/Genus/Species) | Haematococcaceae/Haematoccus/H.pluvialis | |
| Part of plant | Thallus | |
| Solvent extraction | 30% water & 70% ethanol | |
| Country of Origin: | China | |
| Excipent | None | |
| ANALYSIS ITEMS | SPECIFICATION | TEST METHOD |
| Appearance | Fine powder | Organoleptic |
| Color | Dark red | Visual |
| Odour & Taste | Characteristic | Organoleptic |
| Identification | Identical to R.S. sample | HPTLC |
| Astaxanthin | 5%~50% | HPLC |
| Solubility | Partly soluble in water | Organoleptic |
| Hydrocarbons PAHs | ≤ 50 ppb -Reg.UE 1933/2015 | GC-MS |
| Benzo(a)pyren | ≤ 10 ppb -Reg.UE 1933/2015 | GC-MS |
| Radioactivity | ≤ 600 Bq/Kg -Reg. CE 1409/2009 | Gamma spectrometry |
| Apparent density | 0.4-0.7g/ml | Eur.Ph. <2.9.34> |
| Sieve Analysis | 100% through 80 mesh | USP39 <786> |
| Loss on drying | ≤ 5.0% | Eur.Ph.9.0 [2.5.12] |
| Total Ash | ≤ 5.0% | Eur.Ph.9.0 [2.4.16] |
| Lead (Pb) | ≤ 3.0 mg/kg | Eur.Ph.9.0<2.2.58>ICP-MS |
| Arsenic (As) | ≤ 1.0 mg/kg | Eur.Ph.9.0<2.2.58>ICP-MS |
| Cadmium(Cd) | ≤ 1.0 mg/kg | Eur.Ph.9.0<2.2.58>ICP-MS |
| Mercury(Hg) | ≤ 0.1 mg/kg -Reg.EC629/2008 | Eur.Ph.9.0<2.2.58>ICP-MS |
| Heavy metal | ≤ 10.0 mg/kg | Eur.Ph.9.0 <2.4.8> |
| Solvents Residue | Conform Eur.ph. 9.0 <5,4 > and EC European Directive 2009/32 | Eur.Ph.9.0<2.4.24> |
| Pesticides Residues | Conform Regulations(EC) No.396/2005 including annexes and successive updates Reg.2008/839/CE | Gas Chromatography |
| Aerobic bacteria(TAMC) | ≤1000 cfu/g | USP39 <61> |
| Yeast/Moulds(TAMC) | ≤100 cfu/g | USP39 <61> |
| Bile-tol.gram- b./Enterobact.: | ≤100 cfu/g | |
| Escherichia coli: | Absent in 1g | USP39 <62> |
| Salmonella spp: | Absent in 25g | USP39 <62> |
| Staphylococcus aureus: | Absent in 1g | |
| Listeria Monocytogenens | Absent in 25g | |
| Aflatoxins B1 | ≤ 5 ppb -Reg.EC 1881/2006 | USP39 <62> |
| Aflatoxins ∑ B1, B2, G1, G2 | ≤ 10 ppb -Reg.EC 1881/2006 | USP39 <62> |
Astaxanthin has excellent oxidation resisting activity.
Astaxanthin can prevent arteriosclerosis and relative diseases.
Astaxanthin can be used as anticancer activity to strengthen the functions of immune system.
Astaxanthin can enhance the health of central nervous system.
Astaxanthin can intensify energy metabolism of organism.
Astaxanthin has rich nutritional value and good coloring effect.
PRODUCT APPLICATION
A.Astaxanthin can applied in the health care supplements field
B.Astaxanthin can applied in the medicine field
C.Astaxanthin can applied in the beauty and make-up field
D.Astaxanthin can applied in the agricultural feed field
COMPANY PROFILE
Suppliers with verified business licenses
Audited Supplier 
){kind=link}
){kind=link}